ARPO Aerpio Pharmaceuticals Inc.

Aerpio Pharmaceuticals Inc is a biopharmaceutical company. It focuses on advancing first-in-class treatments for ocular diseases.

As of 06/24/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/08/2017
Outstanding shares:  47,371,482
Average volume:  1,309,458
Market cap:   $85,268,668
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00810B105
ISIN:        US00810B1052
Sedol:      BZHJVR8
Valuation   (See tab for details)
PE ratio:   18.08
PB ratio:   1.73
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy